In a KRAS-driven mouse model of lung cancer, aberrantly elevated fructose-1,6-bisphosphatase (FBP1) expression in NK cells from the tumor microenvironment impaired their function by inhibiting glycolysis and reducing their proliferation and viability [127]. The gene discussed is FBP1; the disease is neoplasm.